| CAS No | Product Name | Molecular Formula |
|---|---|---|
| 331416-38-7 | 1-(1-Hydroxy-2-Methyl-2-Propanyl)-2-Aziridinecarboxylic Acid | Csub7/subHsub13/subNOsub3/sub |
| 331417-02-8 | 2-(4-Ethyl-2-Quinazolinyl)Guanidine | Csub11/subHsub13/subNsub5/sub |
| 331424-63-6 | 2-Nitrothieno[3,4-b]Pyridine-5,7-Diamine | Csub7/subHsub6/subNsub4/subOsub2/subS |
| 331432-91-8 | 5-Bromo-1-(Tert-Butyldimethylsilyl)-1H-Indole | |
| 331435-43-9 | N-(2,4-Dichlorophenyl)-2-methoxybenzamide | Csub14/subHsub11/subClsub2/subNOsub2/sub |
| 331442-12-7 | N-Boc-4-hydroxy-L-proline | |
| 331443-00-6 | 4-Hydroxyresveratrol | Csub14/subHsub12/subOsub4/sub |
| 331445-67-1 | 3-[(2E)-3-(2-Chlorophenyl)-2-Propenoyl]-4,6-Dimethyl-2(1H)-Pyridinone | Csub16/subHsub14/subClNOsub2/sub |
| 331459-16-6 | 4-(Methyleneamino)Benzoic Acid | Csub8/subHsub7/subNOsub2/sub |
| 331459-18-8 | 1-[4-(Methyleneamino)Phenyl]Ethanone | Csub9/subHsub9/subNO |
| 331463-81-1 | 3-Methoxy-4-[(2-Nitrobenzyl)Oxy]Benzaldehyde | Csub15/subHsub13/subNOsub5/sub |
| 331465-71-5 | Triisobutylazaphosphatrane | Csub18/subHsub39/subNsub4/subP |
| 331627-82-8 | H-Cys-Lys-Asn-Phe-Phe-Trp-Lys-Thr-OH | Csub52/subHsub72/subNsub12/subOsub11/subS |
| 331633-72-8 | 3-Amino-3-Cyclopropylpropanoic Acid | Csub6/subHsub11/subNOsub2/sub |
| 331636-68-1 | 1-(4-Methoxybenzoyl)-2-(1-Naphthoyl)-Hydrazine | Csub19/subHsub16/subNsub2/subOsub3/sub |
| 331645-84-2 | N-Allyl-2-[(3,4-Dichlorophenyl)Amino]-6-Nitro-4-Oxo-3,4-Dihydro-8-Quinazolinecarboxamide | Csub18/subHsub13/subClsub2/subNsub5/subOsub4/sub |
| 331646-89-0 | 2,4-Dihydroxy-6-nitroquinazoline-8-carboxylic acid | Csub9/subHsub5/subNsub3/subOsub6/sub |
| 331646-98-1 | 8-Bromo-1H-Benzo[d][1,3]Oxazine-2,4-Dione | Csub8/subHsub4/subBrNOsub3/sub |
| 331646-99-2 | 8-Bromoquinazoline-2,4-diol | Csub8/subHsub5/subBrNsub2/subOsub2/sub |
| 331647-00-8 | 8-Bromo-2,4-dichloro-6-nitroquinazoline | Csub8/subHsub2/subBrClsub2/subNsub3/subOsub2/sub |
| 331647-05-3 | 8-Bromo-2,4-dichloroquinazoline | Csub8/subHsub3/subBrClsub2/subNsub2/sub |
| 331647-38-2 | 2,4-Dihydroxyquinazoline-8-carboxylic acid methyl ester | Csub10/subHsub8/subNsub2/subOsub4/sub |
| 331652-58-5 | 3,5-Dimethyl-1-(4-nitrophenyl)piperazine | Csub12/subHsub17/subNsub3/subOsub2/sub |
| 331657-28-4 | 1-(4-Chloro-2-Nitrophenyl)-3-Methylpiperazine Hydrochloride (1:1) | Csub11/subHsub15/subClsub2/subNsub3/subOsub2/sub |
| 331659-12-2 | 2-(2-Amino-4-Ethoxyphenyl)-1H-Isoindole-1,3(2H)-Dione | Csub16/subHsub14/subNsub2/subOsub3/sub |
| 331662-64-7 | 5-Methoxy-4-Oxo-1,4-Dihydro-3-Quinolinecarbonitrile | Csub11/subHsub8/subNsub2/subOsub2/sub |
| 331668-77-0 | 2-(Diethylamino)-1-(2-Naphthyl)-1-Propanone | Csub17/subHsub21/subNO |
| 331670-04-3 | 2-[(4-Methylphenoxy)Methyl]-3-Furoic Acid | Csub13/subHsub12/subOsub4/sub |
| 331670-05-4 | 5-Methyl-4-[(4-Methylphenoxy)Methyl]-2-Furoic Acid | Csub14/subHsub14/subOsub4/sub |
| 331679-72-2 | 6-Methoxy-4-methylbenzothiazol-2-amine | Csub9/subHsub10/subNsub2/subOS |
| 331679-74-4 | 6-Methoxy-4-Methyl-2(3H)-Benzothiazolone Hydrazone | Csub9/subHsub11/subNsub3/subOS |
| 331686-36-3 | Iron(II) 2-ethylhexanoate Monoisopropoxide | |
| 331711-38-7 | (5Z)-5-(3-Bromo-2-Hydroxy-5-Methoxybenzylidene)-2-Thioxo-1,3-Thiazolidin-4-One | Csub11/subHsub8/subBrNOsub3/subSsub2/sub |
| 331711-99-0 | 1,8-Naphthalenediol dibenzoate | Csub24/subHsub16/subOsub4/sub |
| 331713-74-7 | N-(9-Ethyl-9H-Carbazol-3-Yl)-3-Oxobutanamide | Csub18/subHsub18/subNsub2/subOsub2/sub |
| 331713-76-9 | N-(2-Chlorobenzyl)-3-Oxobutanamide | Csub11/subHsub12/subClNOsub2/sub |
| 331713-77-0 | N-(2-Methoxybenzyl)-3-Oxobutanamide | Csub12/subHsub15/subNOsub3/sub |
| 331714-58-0 | 5-Formylisophthalonitrile | Csub9/subHsub4/subNsub2/subO |
| 331714-59-1 | 4-Formylisophthalonitrile | Csub9/subHsub4/subNsub2/subO |
| 331717-42-1 | DL-2-Hydroxyvaleric Acid, Sodium Salt, Hydrate | Csub5/subHsub9/subOsub3/sub |
| 331717-43-2 | D(-)-Amethopterin Hydrate | |
| 331717-44-3 | Silver(1+) Perchlorate Hydrate (1:1:1) | Hsub2/subAgClOsub5/sub |
| 331717-45-4 | N,N-Dimethyl-N-(3-sulfopropyl)-3-[[(3alpha,5beta,7alpha,12alpha)-3,7,12-trihydroxy-24-oxocholan-24-yl]amino]-1-propanaminium inner salt hydrate (1:?) | Csub32/subHsub58/subNsub2/subOsub7/subS.x(Hsub2/subO) |
| 331717-63-6 | 1-Ethyl-3-methylimidazolium thiocyanate | Csub7/subHsub11/subNsub3/subS |
| 331718-48-0 | 4-(3,4-Difluorophenylethynyl)Phenol | |
| 331720-17-3 | Iron(III) 2-ethylhexanoate diisopropoxide | |
| 331727-33-4 | (2E)-1-(2,3-Dihydro-1,4-Benzodioxin-6-Yl)-3-(2-Methoxyphenyl)-2-Propen-1-One | Csub18/subHsub16/subOsub4/sub |
| 331730-08-6 | 3-(2-Furyl)-N-{[(2-Methyl-2-Propanyl)Oxy]Carbonyl}-L-Alanine - N-Cyclohexylcyclohexanamine (1:1) | Csub24/subHsub40/subNsub2/subOsub5/sub |
| 331730-09-7 | 3-(2-Furyl)-N-{[(2-Methyl-2-Propanyl)Oxy]Carbonyl}-D-Alanine - N-Cyclohexylcyclohexanamine (1:1) | Csub24/subHsub40/subNsub2/subOsub5/sub |
| 331731-18-1 | Adalimumab | Csub64/subsub28/subHsub99/subsub12/subNsub16/subsub94/subOsub19/subsub87/subSsub46/sub |